Loading stock data...

Oxygenta Pharmaceutical Ltd.

BSE: OXYGENTAPH

BSE
60.03 0.89 (1.50%)

Prev Close

59.14

Open Price

59.02

Volume

81,534

Today Low / High

59.02 / 61.5

52 WK Low / High

53.56 / 133.5

Range

57 - 63

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 60.03, reflecting a change of 0.89 (1.5049%). The expected target range on the BSE is 57 - 63. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

21 Nov 59.02 1.71%
19 Nov 60.50 -0.30%
18 Nov 63.76 -2.93%
17 Nov 62.99 -1.06%
14 Nov 63.99 -4.94%
13 Nov 64.96 -6.14%
12 Nov 61.85 2.99%
11 Nov 62.10 -0.40%
10 Nov 64.00 -2.63%
07 Nov 66.84 -3.55%
06 Nov 68.88 -2.96%
04 Nov 63.40 4.43%
03 Nov 61.55 5.39%
31 Oct 62.99 1.10%
30 Oct 63.00 -1.94%
29 Oct 64.20 -1.31%
28 Oct 64.90 -1.56%
27 Oct 57.15 9.15%

Oxygenta Pharmaceutical Ltd. Graph

Oxygenta Pharmaceutical Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Oxygenta Pharmaceutical Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 60.03, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 60.03 60.63 54.57 - 66.69
61.23 48.98 - 73.48
61.83 43.28 - 80.38
Bearish Scenario 60.03 59.43 53.49 - 65.37
58.83 47.06 - 70.60
58.23 40.76 - 75.70

Overview of Oxygenta Pharmaceutical Ltd.

ISIN

INE102E01018

Industry

Medical - Pharmaceuticals

Vol.Avg

14,821

Market Cap

2,220,119,505

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for OXYGENTAPH

Metric Value Recommendation
Overall Rating C Sell
DCF Score 1 Strong Sell
ROE Score 5 Strong Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 109.30 Cr 107.63 Cr 1.67 Cr 0.0153 0.00 Cr 2.00 Cr -11.73 Cr -10.30 Cr -2.81 -7.12 Cr -0.0942
2024-03-31 39.64 Cr 49.62 Cr -9.98 Cr -0.2517 0.00 Cr 2.14 Cr -12.36 Cr -3.48 Cr -1.09 -9.62 Cr -0.0878
2023-03-31 30.99 Cr 30.58 Cr 0.41 Cr 0.0133 0.00 Cr 0.68 Cr -9.16 Cr -11.57 Cr -8.15 -7.83 Cr -0.3734
2022-03-31 60.52 Cr 56.57 Cr 3.96 Cr 0.0654 0.00 Cr 1.51 Cr -0.10 Cr -0.61 Cr -0.48 2.03 Cr -0.0101
2021-03-31 52.03 Cr 42.30 Cr 9.73 Cr 0.1870 0.00 Cr 1.33 Cr 2.66 Cr 2.93 Cr 2.87 6.12 Cr 0.0563

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.00 Cr 82.80 Cr 108.44 Cr -25.6405 Cr 62.23 Cr 62.23 Cr 20.51 Cr 37.06 Cr 0.00 Cr 0.00 Cr 1.81 Cr 85.8474 Cr
2024-03-31 0.00 Cr 63.19 Cr 83.31 Cr -20.1224 Cr 57.23 Cr 57.23 Cr 13.72 Cr 29.36 Cr 0.66 Cr 0.00 Cr -0.05 Cr 33.6951 Cr
2023-03-31 0.02 Cr 54.26 Cr 100.46 Cr -46.2000 Cr 67.99 Cr 67.98 Cr 11.71 Cr 27.91 Cr 0.00 Cr 0.00 Cr 0.45 Cr 29.8171 Cr
2022-03-31 0.07 Cr 31.18 Cr 65.81 Cr -34.6291 Cr 52.13 Cr 52.06 Cr 7.28 Cr 20.32 Cr 0.00 Cr 0.00 Cr 0.84 Cr 8.0411 Cr
2021-03-31 0.37 Cr 33.86 Cr 71.88 Cr -38.0186 Cr 47.89 Cr 47.52 Cr 12.11 Cr 16.97 Cr 0.00 Cr 0.00 Cr 0.00 Cr 18.8367 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.8437 Cr -11.2716 Cr 10.4487 Cr -8.7887 Cr 0.0209 Cr 0.1217 Cr -11.3915 Cr -14.3514 Cr 4.9988 Cr 0.0000 Cr -6.7965 Cr
2024-03-31 -13.0496 Cr -4.0878 Cr 17.1320 Cr -18.7315 Cr -0.0054 Cr 0.1008 Cr -4.1056 Cr -3.4793 Cr -10.7598 Cr 0.0000 Cr -2.0114 Cr
2023-03-31 -1.6337 Cr -9.6399 Cr 11.2241 Cr -12.7611 Cr -0.0495 Cr 0.1062 Cr -9.6450 Cr -11.5710 Cr 12.7117 Cr 0.0000 Cr -4.4220 Cr
2022-03-31 -1.6799 Cr -4.9411 Cr 6.3317 Cr -7.5460 Cr -0.2893 Cr 0.1557 Cr -4.9456 Cr -0.6105 Cr 3.2566 Cr 0.0000 Cr 4.8306 Cr
2021-03-31 -1.6219 Cr -6.7187 Cr 8.6673 Cr -8.3632 Cr 0.3267 Cr 0.4450 Cr -6.7412 Cr 3.1438 Cr 10.4502 Cr 0.0000 Cr -7.8606 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 14.25 Cr 19.12 Cr -4.88 Cr -0.3423 -5.49 Cr -4.93 Cr -1.33 -4.63 Cr -0.3461
2025-06-30 15.13 Cr 18.82 Cr -3.68 Cr -0.2433 -7.68 Cr -6.11 Cr -1.65 -6.67 Cr -0.4035
2025-03-31 49.47 Cr 47.23 Cr 2.24 Cr 0.0452 -1.40 Cr -2.15 Cr -0.59 -1.90 Cr -0.0435
2024-12-31 33.21 Cr 35.05 Cr -1.85 Cr -0.0556 -5.06 Cr -3.93 Cr -1.07 -3.87 Cr -0.1183
2024-09-30 14.01 Cr 13.40 Cr 0.61 Cr 0.0435 -2.83 Cr -2.85 Cr -0.81 -1.42 Cr -0.2038

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 1.24 Cr 0.00 Cr 1.24 Cr 15.73 Cr 27.09 Cr 51.92 Cr 41.55 Cr 116.77 Cr 153.44 Cr
2025-03-31 0.00 Cr 0.12 Cr 0.12 Cr 5.10 Cr 20.51 Cr 30.94 Cr 37.06 Cr 82.80 Cr 108.44 Cr
2024-09-30 0.00 Cr 0.10 Cr 0.10 Cr 15.16 Cr 14.09 Cr 32.33 Cr 29.82 Cr 73.25 Cr 94.39 Cr
2024-03-31 0.00 Cr 0.10 Cr 0.10 Cr 7.37 Cr 14.13 Cr 24.11 Cr 29.36 Cr 63.19 Cr 83.31 Cr
2023-09-30 0.01 Cr 0.08 Cr 0.09 Cr 16.27 Cr 12.70 Cr 32.30 Cr 29.75 Cr 64.16 Cr 88.60 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 -3.36 Cr 1.38 Cr 0.00 Cr 0.00 Cr 1.38 Cr 1.38 Cr 0.01 Cr 0.00 Cr 1.38 Cr
2023-09-30 -3.16 Cr -3.16 Cr 0.00 Cr 0.00 Cr -3.16 Cr 0.01 Cr 3.17 Cr 0.00 Cr -3.16 Cr
2023-06-30 -4.56 Cr -4.56 Cr 0.00 Cr 0.00 Cr -4.67 Cr -4.56 Cr 0.11 Cr 0.00 Cr -4.56 Cr
2023-03-31 -4.29 Cr -4.29 Cr 0.00 Cr 0.00 Cr -4.29 Cr 0.11 Cr 4.40 Cr 0.00 Cr -4.29 Cr
2022-12-31 -3.25 Cr -3.25 Cr 0.00 Cr 0.00 Cr -3.25 Cr -3.25 Cr 0.00 Cr 0.00 Cr -3.25 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹767.40 ₹91,909,729,910.00 ₹138,681.00

Key Executives

Chief Financial Officer
Mr. Prasad Reddy Battinapatla

Gender: male

Year Born:

HR & Admin of Manager
M. Sreedhar Reddy

Gender: Not Specified

Year Born:

Additional Executive Director
Mr. Balasubba Reddy Mamilla

Gender: male

Year Born: 1964

Head of Marketing
Annem Chandra Obula Reddy

Gender: Not Specified

Year Born:

Senior General Manager of Administration
Satyanarayana Reddy Bandi

Gender: Not Specified

Year Born:

Company Secretary & Compliance Officer
Ms. Kumkum Bajaj

Gender: female

Year Born:

Additional Executive Director
Mr. Chandrasekhar Reddy Gangavaram

Gender: male

Year Born: 1962

FAQs about Oxygenta Pharmaceutical Ltd.

Who is the CEO of the company?

The CEO is Prasad Reddy Battinapatla.

What is the current market price of the stock?

The current price is ₹60.03.

What is the 52-week price range?

The range is ₹53.56-133.5.

What is the market capitalization of the company?

The market capitalization is ₹222.01 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -12.97.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Oxygenta Pharmaceutical Ltd. (ISIN: INE102E01018) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹222.01 crores and an average daily volume of 14,821 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.